Article Text

Download PDFPDF
24 Drug coated balloon-only angioplasty in chronic total occlusions, a UK single centre experience
  1. Upul Wickramarachchi,
  2. Natasha H Corballis,
  3. Clint A Maart,
  4. Timothy J Gilbert,
  5. Simon C Eccleshall
  1. Norfolk and Norwich University Hospital NHS Foundation Trust

Abstract

Objective Chronic total occlusions (CTO) are encountered in 15%–30% of patients referred for coronary angiography. We report outcomes of Drug Coated Balloon (DCB) – only angioplasty for CTO’s in a UK high volume PCI centre.

Methods Retrospectively we identified 41 consecutive patients with 44 CTO’s treated from 14/12/2011 to 01/06/2016. Clinical outcomes were obtained from the clinic follow up letters and up-to-date mortality data from the Demographic Batch Service Bureau of the Health and Social Care Information Centre.

Results Mean (SD) age 62.1 (9.5) years, 85.4% males, 34.1% Japanese CTO score of ≥2% and 40.9% had a score of 1. 81.8% de novo lesions, 43.2% multi-vessel disease, 47.7% LAD lesions. Dual access was used in 52.3%, anterograde wiring technique was successful in 97.7%. Mean (SD) DCB diameter was 2.8 (0.6) mm and mean (SD) length of treated segment was 41 (26) mm. There were 15 (34.1%) coronary dissections and two required bail-out stenting. There was one non-cardiac death but no cardiac deaths at a mean (SD) follow up period of 630 (347) days. After a mean (SD) clinic follow up period of 313 (304) days there were 3 (6.8%) target lesion revascularisations, 1 (2.3%) staged target vessel revascularisation (TVR) and 1 (2.3%) non- target vessel related non ST elevation myocardial infarction. Major adverse cardiac event rate was 9.8%. 17 (41.5%) had follow up angiography and no re-occlusions.

Conclusion DCB-only angioplasty to CTOs appears to be a safe and effective treatment in the medium term follow up. This is the largest cohort reported and the first in the UK.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.